BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3098287)

  • 1. Inactivation of plasminogen activator inhibitor by oxidants.
    Lawrence DA; Loskutoff DJ
    Biochemistry; 1986 Oct; 25(21):6351-5. PubMed ID: 3098287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor 2 (PAI-2) is not inactivated by exposure to oxidants which can be released from activated neutrophils.
    Baker MS; Green SP; Goss N; Katrantzis M; Doe WF
    Biochem Biophys Res Commun; 1990 Jan; 166(2):993-1000. PubMed ID: 2154227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of plasminogen activator inhibitor (PAI) capacity of human plasma in presence of oxidants: a novel principle.
    Stief TW; Lenz P; Becker U; Heimburger N
    Thromb Res; 1988 May; 50(4):559-73. PubMed ID: 3137681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cells.
    Mimuro J; Loskutoff DJ
    J Biol Chem; 1989 Mar; 264(9):5058-63. PubMed ID: 2494180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endotoxin-induced secretion of an active plasminogen activator inhibitor from bovine pulmonary arterial and aortic endothelial cells.
    Crutchley DJ; Conanan LB; Ryan US
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1346-53. PubMed ID: 3120714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of plasminogen activator inhibitor 1 (PAI-1).
    Lindahl TL; Sigurdardottir O; Wiman B
    Thromb Haemost; 1989 Sep; 62(2):748-51. PubMed ID: 2479113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.
    Sawdey M; Podor TJ; Loskutoff DJ
    J Biol Chem; 1989 Jun; 264(18):10396-401. PubMed ID: 2499579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine plasminogen activator inhibitor 1: specificity determinations and comparison of the active, latent, and guanidine-activated forms.
    Hekman CM; Loskutoff DJ
    Biochemistry; 1988 Apr; 27(8):2911-8. PubMed ID: 2969749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid inactivation of the plasminogen-activator inhibitor upon secretion from cultured human endothelial cells.
    Kooistra T; Sprengers ED; van Hinsbergh VW
    Biochem J; 1986 Nov; 239(3):497-503. PubMed ID: 3103601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone-induced inhibitor of plasminogen activator in hepatoma cells is antigenically-related to an inhibitor produced by bovine aortic endothelial cells.
    Loskutoff DJ; Roegner K; Erickson LA; Schleef RR; Huttenlocher A; Coleman PL; Gelehrter TD
    Thromb Haemost; 1986 Feb; 55(1):8-11. PubMed ID: 3486492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor.
    Mimuro J; Schleef RR; Loskutoff DJ
    Blood; 1987 Sep; 70(3):721-8. PubMed ID: 3113515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C.
    Fay WP; Owen WG
    Biochemistry; 1989 Jul; 28(14):5773-8. PubMed ID: 2505842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.
    van Mourik JA; Lawrence DA; Loskutoff DJ
    J Biol Chem; 1984 Dec; 259(23):14914-21. PubMed ID: 6438106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonradical oxidants of the phagocyte type induce the activation of plasmatic single chain- urokinase.
    Stief TW; Stief MH; Ehrenthal W; Darius H; Martin E
    Thromb Res; 1991 Dec; 64(5):597-610. PubMed ID: 1808764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix plasminogen activator inhibitor. Modulation of the extracellular proteolytic environment.
    Knudsen BS; Nachman RL
    J Biol Chem; 1988 Jul; 263(19):9476-81. PubMed ID: 2967824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.
    Hekman CM; Loskutoff DJ
    J Biol Chem; 1985 Sep; 260(21):11581-7. PubMed ID: 3930479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid treatment of plasma for the inactivation of plasminogen activator inhibitor-1 (PAI-1).
    de Maat MP; Kluft C; de Boer K; Knot EA; Jie AF
    Thromb Res; 1988 Dec; 52(5):425-30. PubMed ID: 3146821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
    Gyetko MR; Webb AC; Sitrin RG
    J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.
    Levin EG; Santell L
    J Cell Biol; 1987 Dec; 105(6 Pt 1):2543-9. PubMed ID: 3121634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoaffinity purification of HTC rat hepatoma cell plasminogen activator-inhibitor-1.
    Zeheb R; Rafferty UM; Rodriguez MA; Andreasen P; Gelehrter TD
    Thromb Haemost; 1987 Dec; 58(4):1017-23. PubMed ID: 3127913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.